Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment

por Jagmohan Singh, Wilbur B. Bowne, Adam E. Snook
Publicado 2021

Anti-Tumor Efficacy of an Adjuvant Built-In Nanovaccine Based on Ubiquitinated Proteins from Tumor Cells

por Huang F, Zhao J, Wei Y, Wen Z, Zhang Y, Wang X, Shen Y, Wang L, Pan N
Publicado 2020

Genetically-engineered “all-in-one” vaccine platform for cancer immunotherapy

por Aihua Wu, Yingzhi Chen, Hairui Wang, Ya Chang, Meng Zhang, Pengfei Zhao, Yisi Tang, Qin Xu, Zhuangzhi Zhu, Yang Cao, Yongzhuo Huang
Publicado 2021

Roles of Microvesicles in Tumor Progression and Clinical Applications

por Zhu S, Li S, Yi M, Li N, Wu K
Publicado 2021

In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines

por Orsolya Lőrincz, József Tóth, Levente Molnár, István Miklós, Kata Pántya, Mónika Megyesi, Eszter Somogyi, Zsolt Csiszovszki, Enikő R. Tőke
Publicado 2021

CELLULAR IMMUNOTHERAPY: A MODERN APPROACH TO TREATMENT OF ONCOLOGICAL DISEASES

por Yu. N. Lezhnin, A. Yu. Khristichenko, N. M. Ratnikova, Yu. E. Kravchenko, S. P. Chumakov
Publicado 2018

A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study

por An-Wen Xiong, Jue-Min Fang, Sheng-Xiang Ren, Wei Li, Jing Wang, Yu Zhao, Guo-You Chen, Qing Xu, Cai-Cun Zhou
Publicado 2021

Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies

por Uri Galili
Publicado 2021

The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma

por Ricki T. Krog, Noel F. C. C. de Miranda, Alexander L. Vahrmeijer, Nigel G. Kooreman
Publicado 2021

Commensal <i>Bifidobacterium</i> Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines

por Michele Tomasi, Mattia Dalsass, Francesco Beghini, Ilaria Zanella, Elena Caproni, Laura Fantappiè, Assunta Gagliardi, Carmela Irene, Enrico König, Luca Frattini, Giulia Masetti, Samine Jessica Isaac, Federica Armanini, Fabio Cumbo, Aitor Blanco-Míguez, Alberto Grandi, Nicola Segata, Guido Grandi
Publicado 2021

Personalized immunotherapy in cancer precision medicine

por Kazuma Kiyotani, Yujiro Toyoshima, Yusuke Nakamura
Publicado 2021

A Personalized Neoantigen Vaccine in Combination with Platinum-Based Chemotherapy Induces a T-Cell Response Coinciding with a Complete Response in Endometrial Carcinoma

por Alexandre Harari, Apostolos Sarivalasis, Kaat de Jonge, Anne-Christine Thierry, Florian Huber, Caroline Boudousquie, Laetitia Rossier, Angela Orcurto, Martina Imbimbo, Petra Baumgaertner, Michal Bassani-Sternberg, Lana E. Kandalaft
Publicado 2021

The Advantages and Challenges of Anticancer Dendritic Cell Vaccines and NK Cells in Adoptive Cell Immunotherapy

por Elena V. Abakushina, Liubov I. Popova, Andrey A. Zamyatnin, Jens Werner, Nikolay V. Mikhailovsky, Alexandr V. Bazhin
Publicado 2021

The future of tumor vaccines in the post‐COVID‐19 era—Current challenges

por Panagiotis F. Christopoulos
Publicado 2021

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma

por Alessandra Lopes, Kevin Vanvarenberg, Špela Kos, Sophie Lucas, Didier Colau, Benoît Van den Eynde, Véronique Préat, Gaëlle Vandermeulen
Publicado 2018

EFFICIENCY OF THE FORMATION OF ANTITUMOR IMMUNE RESPONSES IN THE SYSTEM OF PREVENTIVE VACCINATION OF MICE WITH TESTICULAR ANTIGENS

por A. B. Dorzhieva, T. S. Khabalova, Yu. E. Androsova, E. A. Kaschenko, I. P. Ivanova, G. V. Seledtsova
Publicado 2021

SELECTED ASPECTS OF ALLO- AND XENOGRAFT MODEL APPLICATIONS FOR DEVELOPING NOVEL ANTI-CANCER VACCINES AND ONCOLYTIC VIRUSES

por T. S. Nepomnyashchikh, E. V. Gavrilova, R. A. Maksyutov
Publicado 2019

Biological Therapies in the Treatment of Cancer—Update and New Directions

por Monika A. Papież, Wirginia Krzyściak
Publicado 2021